Cite
HARVARD Citation
Hofman, M. et al. (2020). Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 395 (10231), pp. 1208-1216. [Online].